Dosing information in renal impairment

Size: px
Start display at page:

Download "Dosing information in renal impairment"

Transcription

1 No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > mg/kg q 12 hr mg/kg q 24 hr < mg/kg q 48 hr 15 mg per kg Once Daily > mg/kg/day mg/kg/day mg/kg/day mg/kg/day mg/kg q 48 hr mg/kg q 48 hr < 10 3 mg/kg q 72 hr and AD 1.7 mg/kg q 8 hr > % q 8 hr % q hr < % 48 hr 5.1 mg per kg Once Daily > mg/kg/day, mg/kg/day mg/kg/day, mg/kg/day mg/kg q 48 hr, mg/kg q 48 hr < 10 2 mg/kg q 72 hr and AD HD, CAPD HD: ½ of normal renal function dose AD CAPD : mg lost per L dialysate per day HD: ½ of normal renal function dose AD CAPD: 3-4 mg lost per L dialysate per day 1

2 3 Streptomycin sulfate 4 Kanamycin 15 mg/kg (max. of 1.0 g) q 24 hr > mg/kg q 24 hr mg/kg q hr < mg/kg q hr 15 mg per kg once daily > mg/kg/day mg/kg/day mg/kg/day mg/kg/day mg/kg q 48 hr mg/kg q 48 hr < 10 3 mg/kg q 72 hr and AD mg/ kg 8-12 hr % q 12 hr 60-90% q 8-12 hr % q 12 hr < % q hr 15 mg per kg once daily > mg/kg/day mg/kg/day mg/kg/day mg/kg/day mg/kg q 48 hr mg/kg q 48 hr < 10 3 mg/kg q 72 hr or AD HD: ½ of normal renal function dose AD CAPD: mg lost per L dialysate per day HD: Extra 50% of normal renal Function dose AD CAPD: mg lost per L of Dialysate per day 2

3 5 Netilmicin 2 mg/kg q 8 hr Once Daily Dosing > % normal dose q 8 hr % normal dose q hr < % normal dose q 48 hr > mg/kg q 24 hr mg/kg q 24 hr mg/kg q 24 hr mg/kg q 24 hr mg/kg q 48 hr mg/kg q 48 hr < mg/kg q 72 hr and AD Carbapenem antibiotics 6 Imipenem 0.5 g q 6 hr > mg q 6-8 hr mg q 6-12 hr Dose for CRRT: gm bid < mg q 12 hr 7 Meropenem 1.0 gm q 8 hr > gm q 8 hr gm q 12 hr same dose for CRRT < gm q 24 hr HD: Extra 50% of normal renal function dose AD CAPD: 3-4 mg lost per L dialysate per day (refer to timing of dose) 3

4 8 Doripenem 500 mg IV q 8 hr > mg IV q 8 hr mg IV q 8 hr >10 - < mg IV q 12 hr <10 no data 9 Ertapenem 1.0 gm q 24 hr > gm q 24 hr gm q 24 hr (CrCl < 30 ) < gm q 24 hr Cephalosporin Antibiotics 10 Cefazolin Sodium 1-2 g q 8 hr > g q 8 hr g q 12 hr < g q hr 11 Cefotaxime 2 g q 8 hr > g q 8-12 hr g q hr < 10 2 g q 24 hr 12 Cefoxitin 2 g q 8 hr > g q 8 hr g q 8-12 hr < 10 2 g q hr 13 Ceftazidime 2 g q 8 hr > g q 8-12 hr g q hr < 10 2 g q hr NO data HD: Dose as for CrCl <10;if dosed < 6 hrs prior to HD, give 150 mg supplement AD HD: g AD CAPD: 0.5 g q 12 hr HD: Extra 1 g AD CAPD: g q 24 hr HD: Extra 1 g AD CAPD: 1 g q 24 hr HD: Extra 1 g AD CAPD: 0.5 g q 24 hr 4

5 14 Cefuroxime Sodium inj g q 8 hr > g q 8 hr g q 12 hr < g q 24 hr 15 Cefoperazone 1 g +Sulbactam 0.5 g (Sulperazon 1.5 g) g/ day IM or IV Divided q 12 hr up to Max.12 g of 2:1 ratio Max. Sulbactam 4 g/day Max. Sulbactam 2 g/day (1 g q 12 h) <15 Max. Sulbactam 1 g/day (500 mg q 12h) HD: 1.5 g Sulperazon AD CAPD: No adjustment 16 Ceftriaxone 1-2 g q hr No adjustment in renal failure CAPD: 1 g q 12 hr 17 Cefuroxime axetil (oral form) mg q 12 hr normal dose q 12 hr < 10 normal dose q 24 hr CAPD: Dose as for CrCl < Cephalexin mg orally q 6-8 hr < mg q 12 hr HD: Normal Dose AD CAPD: Dose as for CrCl < Cefepime 2.0 gm q 8 hr (max dose) > gm q 8 hr gm q hr same dose for CRRT < 10 1 gm q 24 hr HD : Extra 1 gm AD CAPD : 1-2 gm q 48 hr 5

6 Fluoroquinolone Antibiotics 20 Ciprofloxacin inj. 400 mg q 12 hr or > % mg IV q 24 hr < 10 50% HD: 200 mg IV q 12 hr CAPD: 200 mg IV q 8 hr 21 Norfloxacin 400 mg q 12 hr < mg q 24 hr HD: Dose as for CrCl < 10 CAPD: Insufficient data 22 Ofloxacin mg q 12 hr usual dose q 24 hr HD : 50% of usual dose q 24 hr < 20 50% of usual dose q 24 hr 23 Ciprofloxacin, oral mg q 12 hr > no change % of dose < 10 50% of dose 24 Gatifloxacin 400 mg po/iv q 24 hr > mg q 24 hr mg, then 200 mg q 24 hr same dose fro CRRT < mg, then 200 mg q 24 hr CAPD: 300 mg q 24 hr HD: 250 q 12 hrdose AD CAPD: 250 q 8 hr HD: 200 mg q 24 hr AD CAPD: 200 mg q 24 hr 25 Gemifloxacin 320 mg po q 24 hr > mg q 24 hr HD: 160 mg q 24 hr AD 6

7 mg q 24 hr < mg q 24 hr 26 Levofloxacin 750 mg q 24 hr IV,PO > mg q 24 hr mg q 48 hr < mg once, then 500 mg q 48 hr Macrolide Antibiotics 27 Clarithromycin g q 12 hr > % of normal dose % of normal dose < % of normal dose 28 Erythromycin mg q 6 hr > % % < % Miscellaneous Antibacterial Antibiotics 29 Colistin (Colistimethate Sodium) 150 mg colistin base/vial 30 Cotrimoxazole (Tablet: TMP 80 mg/ SMZ 400 mg ) mg /kg/day Divided 2-4 doses/day Non-PJP: 1 DS Tablet every 12 hr PJP prophylaxis: one DS tablet daily > mg q8-12 hr (300 mg/day) mg q 12 hr mg q hr mg q 36 hr >30 Usual dose < 15 Administer 50% of recommend dose < 15 Not recommended CAPD: 160 mg q 24 hr HD/CAPD Dose for CrCl < 20 HD: Normal Dose AD CAPD: none CAPD: none HD: 80 mg AD HD: Avoid if possible. If unavoidable, give 50% of Maintenance dose q 24 hr on dialysis day dose AD 7

8 31 Trimethoprimsulfamethoxazole-DS PJP treatment:: mg (TMP)/kg/day divided q 6-8 hr Treatment : 5-20 mg/kg/day divided q 6-12 hr Prophylaxis : 1 tab po q 24 hr or 3 times per week > mg/kg/d divided q 6-12 hr mg/kg q 8 hr same dose for CRRT mg/kg q 12 hr < 10 not recommend but if used 5-10 mg/kg per dose q 24 hr > % % <10 100% 32 Vancomycin 1 g q 12 hr > g q 12 hr g q hr < 10 1 g q 4-7 days 33 Clindamycin phosphate inj g/day in 2-4 divided dose 34 Fosfomycin 2-4 g/ day in 2 divided doses No adjustment in renal failure g q 12 hr g q 12 hr mg q 12 hr CAPD: Insufficient data Not recommended: but if used: 5-10 mg/kg q 24 hr HD/ No adjustment HD: 1-2 g ก HD CAPD 1 g q hr 8

9 35 Lincomycin 0.5 g q 6 hr > q 6 hr No adjustment q 6-12 hr < 10 q hr 36 Clindamycin (oral form) mg q 6 hr No adjustment in renal failure No adjustment Penicillin Antibiotics 33 Amoxillin(AM) / clavulanate (oral form) 500 mg/ 125 mg q 8 hr > /125 mg AM component q 8 hr mg of AM component q 12 hr < mg of AM component q 24 hr HD: As for CrCl < 10 extra dose after dialysis 34 Ampicillin 250 mg 2 gm q 6 hr > g q 6 hr g q 6-12 hr < g q hr CAPD: 250 mg q 12 hr 35 Ampicillin/sulbactam 2 gm AM + 1 gm SB or 1 gm AM + 0.5g SB Iv q 6-8 hr 36 Benzathine Penicillin million units Single dose ( 30 ) g q 6-8 hr (15-29) g q 12 hr (5-14) q 24 hr % < % CAPD: 2 gm AM/1 gm SB q 24 hr HD : A maintenance dose may be given to patients following HD 9

10 CAPD : 20 50% normal dose q 6 hr 37 Cloxacillin inj mg q 6 hr No adjustment in renal failure No adjustment 38 Penicillin G million Unit q 4 hr > % of dose % of dose < % of dose 38 Amoxycillin mg q 8 hr > no change q 8-12 hr < 10 q 24 hr 39 Amoxycillin/Clavulanic acid (Augmentin inj. 1.2g ) 1.2 G IV q 8 hr > 30 no change G IV stat followed 600 mg IV q 12 hr < G IV stat followed 600 mg IV q 24 hr HD: dose AD CAPD: 250 mg q 12 hr HD: add 600 mg IV dose AD 40 Dicloxacillin mg q 6 hr No adjustment in renal failure No adjustment 41 Piperacillin(P)/Tazobactam(T) gm q 6-8 hr > % gm q 6 hr if CrCl< 20 q 8 hr same dose for CRRT < gm q 8 hr HD: Dose for CrCl< gm AD CAPD: 4.5 gm q 12 hr, CRRT: 4.5 gm q 48 hr 10

11 Tetracycline Antibiotics 42 Tetracycline mg q 6-12 hr >50-90 q 8-12 hr HD/CAPD: None q hr < 10 q 24 hr 43 Doxycycline 100 mg q 12 hr No adjustment in renal failure No adjustment Antifungal antibiotics 44 Amphotericin B ก ก (Nephrotoxicity) ก Non- lipid: mg/ kg q 24 hr ABLC: 5 mg/kg/day LAB: 3-5 mg/kg/day > q 24 hr q 24 hr < 10 q 24 hr 45 Fluconazole mg q 24 hr > % % < 10 50% 46 1) Itraconazole, po soln mg q 12 hr > % % < 10 50% 2) Itraconazole, IV 200 mg IV q 12 hr > mg IV bid < 50 Do not use IV form if CrCl < 30 due to accumulation of carrier: cyclodextrin 47 Terbinafine 250 mg po per day > q 24 hr < 50 ก ก HD: No adjustment CAPD: No adjustment HD: 100% of recommended dose AD HD/CAPD :oral solution 100 mg q hr 11

12 48 Voriconazole 6 mg/kg IV q 12 hr times 2, then 4 mg/kg q 12 hr > No adjustment If CrCl < 50 ml/min, accum. Of IV vehicle (cyclodextrin). Switch to po or DC 49 Griseofluvin Microsize: g q 24 hr in single or divided doses Ultramicrosize: 375 mg q 24 hr in single or divided doses (max.dose of 750 mg/day) 50 Ketoconazole mg/day as a single daily dose Insufficient data No dose adjustment Insufficient data No dose adjustment 12

13 51 Nystatin Oral candidiasis; 400, ,000 units to each side of mouth qid Intestinal infections; Oral: 500,000-1,000,000 units q 8 hr Insufficient data Insufficient data Antituberculous Antibiotics 52 Ethambutol mg/kg q 24 hr q 24 hr q hr < 10 q 48 hr 53 Isoniazid (INH) 5 mg/kg q 24 hr No adjustment (max 300 mg) 13

14 54 Pyrazinamide 25 mg/kg q 24 hr (max 2.5 g q 24 hr) No adjustment No adjustment < mg/kg q 24 hr HD: 40 mg/kg 24 hrs before each 3x / week dialysis CAPD: No reduction 55 Rifampicin (Rifampin) 600 mg q 24 hr No adjustment mg q 24 hr < mg q 24 hr Antiviral Agents for Antiretroviral 56 Acyclovir, IV mg/kg q 8 hr > % q 8 hr % q hr < 10 50% q 24 hr 57 Adefovir 10 mg po q 24 hr > mg q 24 hr mg q hr < mg q 72 hr 58 Atazanavir ARV-naïve pts: Atazanavir 300 mg OD plus ritonavir No adjustment 100 mg OD or 400 mg OD in patients unable to tolerate ritonavir HD: No adjustment HD: 10 mg q week AD CAPD: No data Use boosted therapy of atazanavir 300 mg with ritonavir 100 mg OD 14

15 ARV- experienced pts: Atazanavir 300 mg OD plus ritonavir 100 mg OD 59 1) Ganciclovir, IV Induction 5 mg/kg q 12 hr IV > mg/kg q 12 hr mg/kg q 24 hr < mg/kg 3 times/wk Maintenance 5 mg/kg q 24 hr IV > mg/kg q 24 hr mg/kg q 24 hr < mg/kg 3 times/wk 2) Ganciclovir, po 1 g tid > g tid g q 24 hr < mg 3 times/wk 60 Oseltamivir 75 mg bid > mg q 12 hr mg bid mg once daily < 10 Insufficient data 61 Valacyclovir 1 g q 8 hr > g q 8 hr g q hr < g q 24 hr 62 Lamivudine 300 mg po q 24 hr > mg q 24 hr mg q 24 hr Not recommended HD: 0.6 mg/kg AD HD: 0.5 g AD HD: 30 mg ก 2 HD CAPD: 30 mg once per week 15

16 < mg q 24 hr 63 Nelfinavir 750 mg tid orally or 1250 bid Insufficient data 64 Nevirapine Initial : 200 mg OD x 14 days Maintenance: 200 mg bid 20 No adjustment An additional 200 mg dose is recommended following HD 65 Ritonavir 600 mg bid Escalate the dose as follows: No adjustment Days 1; 300 mg bid Days 2; 400 mg bid Days 3; 500 mg bid Then 600 mg bid (max. dose) 66 Stavudine mg q 12 hr > % % q hr < kg 20 mg/day < 60 kg 15 mg/day 67 Zidovudine 300 mg q 12 hr > No adjustment No adjustment < mg q 8 hr Insufficient data HD: Dose as for CrCl < 10 AD CAPD No data CRRT Full dose HD: Dose for CrCl < 10 AD CAPD : Dose for CrCl < 10 16

17 Reference 1. ก ก ก ก Lacy CF, et al, Drug information Handbook th ed Philadelphia Lexi- Comp Inc ; Gilbert DN, et al, The Sanford guide to antimicrobial therapy,40 th ed, Antimicrobial Therapy, Inc, Micromedex Health Care Seires, (Electronic version) Thomson Micromedex, Greenwood Village, Cololrado, USA, Available at : http// com.(accessed on 29 October,2010.) 5. Available at: http// (accessed on 7 October,2010.) 6. Myrna Y. Munar and Harleen Singh. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician 2007;75 : (accessed on 17 March,2011) : 1555 ( ). ก. ก... ก. 17

18 18

Date: November 30, 2010

Date: November 30, 2010 Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application

More information

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director

More information

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic

More information

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a

More information

Product Catalogue 2015 Clinical and Industrial Microbiology

Product Catalogue 2015 Clinical and Industrial Microbiology Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

Urinary Tract Infections

Urinary Tract Infections Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of

More information

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication

More information

CANDIDA INFECTIONS - TREATMENT GUIDELINES IN ADULT

CANDIDA INFECTIONS - TREATMENT GUIDELINES IN ADULT Page 1 of 6 TITLE: PATIENTS CANDIDA INFECTIONS - TREATMENT GUIDELINES IN ADULT GUIDELINES: These are the 2011 Guidelines for the Treatment of Candida species infections in adult patients. These recommendations

More information

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx

More information

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):

More information

ANTIBIOTICS IN SEPSIS

ANTIBIOTICS IN SEPSIS ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics

More information

Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010

Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010 J Antimicrob Chemother 2011; 66: 205 209 doi:10.1093/jac/dkq404 Advance Access publication 8 November 2010 Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus

More information

Appendix 4: Guidelines for Prescribing and Administering Drugs:

Appendix 4: Guidelines for Prescribing and Administering Drugs: Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates

More information

Appropriate Treatment for Children with Upper Respiratory Infection

Appropriate Treatment for Children with Upper Respiratory Infection BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare

More information

Guideline. Treatment of tuberculosis in renal disease. Version 3.0

Guideline. Treatment of tuberculosis in renal disease. Version 3.0 Guideline Treatment of tuberculosis in renal disease Version 3.0 Key critical points Renal failure is recognised as a risk factor for developing tuberculosis. Renal failure is recognised as a risk factor

More information

Intra-abdominal abdominal Infections

Intra-abdominal abdominal Infections Intra-abdominal abdominal Infections Marnie Peterson, Pharm.D., BCPS Dept. of Pediatric Infectious Diseases Medical School University of Minnesota Intra-abdominal abdominal Infections Intra-abdominal abdominal

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

UWHC Clinical Directive for Renal Function-Based Dose Adjustments in Adults

UWHC Clinical Directive for Renal Function-Based Dose Adjustments in Adults UWHC Clinical Directive for Renal Function-Based Dose Adjustments in Adults Guidelines developed by UWHC Center for Drug Policy (CDP) Coordination: Lee Vermeulen, MS, RPh, FCCP Authors: William D. Simmons

More information

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES : LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: [email protected] Website: www.locostindia.com A Public

More information

Novel Oral Anticoagulants (NOACs) Prescriber Update 2013

Novel Oral Anticoagulants (NOACs) Prescriber Update 2013 Novel Oral Anticoagulants (NOACs) Prescriber Update 2013 Indications/Contraindications Indications Orthopedic VTE Prophylaxis VTE Treatment Stroke Prevention for non-valvular AF Contraindications 150 mg

More information

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis ANTIBIOTIC-ASSOCIATED DIARRHEA Disturbance of the normal colonic microflora Leading to alterations in bacterial degradation

More information

Disease Site Breast. Less than 120 kg: Cefazolin 2 grams IV Greater than or equal to 120 kg: Cefazolin 3 grams IV. Head & Neck

Disease Site Breast. Less than 120 kg: Cefazolin 2 grams IV Greater than or equal to 120 kg: Cefazolin 3 grams IV. Head & Neck Patients scheduled for surgery should have the following antibiotics administered prior to their procedure Vancomycin and Ciprofloxacin are to be initiated 60 to 120 minutes prior to incision and all other

More information

TREATMENT OF PERITONEAL DIALYSIS (PD) RELATED PERITONITIS. General Principles

TREATMENT OF PERITONEAL DIALYSIS (PD) RELATED PERITONITIS. General Principles WA HOME DIALYSIS PROGRAM (WAHDIP) GUIDELINES General Principles 1. PD related peritonitis is an EMERGENCY early empiric treatment followed by close review is essential 2. When culture results and sensitivities

More information

ORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x

ORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01613.x Benchmarking antimicrobial drug use at university hospitals in five European countries V. Vlahović-Palc evski 1, U. Dumpis 2, P. Mitt 3, J. Gulbinovic

More information

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies 2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies Legislative Authority: Health Insurance Act (Standard Hospital Benefit) Regulations 1971- Section 3(xv) This schedule lists the

More information

SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS

SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS Page 1 of 8 TITLE: SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS GUIDELINE: Antibiotics are administered prior to surgical procedures to prevent surgical site infections. PURPOSE:

More information

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE THE UNITED REPUBLIC OF TANZANIA Treat for Lymphogranuloma venereum MINISTRY OF HEALTH AND SOCIAL WELFARE Appoint to return after Patient complains of Use Discharge from Continue to 2nd Refer to surgeon

More information

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/

More information

Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK

Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK Journal of Antimicrobial Chemotherapy (2001) 48, Suppl. S1, 5 16 Determination of minimum inhibitory concentrations JAC Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham

More information

10. Treatment of peritoneal dialysis associated fungal peritonitis

10. Treatment of peritoneal dialysis associated fungal peritonitis 10. Treatment of peritoneal dialysis associated fungal peritonitis Date written: February 2003 Final submission: July 2004 Guidelines (Include recommendations based on level I or II evidence) The use of

More information

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant

More information

Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy

Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy IDSA GUIDELINES Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy Alan D. Tice, 1 Susan J. Rehm, 2 Joseph R. Dalovisio, 3 John S. Bradley, 4 Lawrence P. Martinelli, 5 Donald R. Graham,

More information

ANTIMICROBIAL USE GUIDELINES

ANTIMICROBIAL USE GUIDELINES ANTIMICROBIAL USE GUIDELINES University of Wisconsin Hospital and Clinics Pharmacy and Therapeutics Committee Department of Pharmacy Drug Policy Program July 2011 to June 2012 Twenty-First Edition PREFACE

More information

HUSRES Annual Report 2015

HUSRES Annual Report 2015 HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses

More information

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12 Page 1 of 12 TITLE: ANTIBIOTICS IN ADULT PATIENTS EMPIRIC USE GUIDELINES, COLUMBIA UNIVERSITY MEDICAL CENTER MEDICATION GUIDELINE PURPOSE: These are the 2011 guidelines for the empiric use of antibiotics

More information

Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections

Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections University of Wisconsin Hospital and Clinics Intraabdominal Infections Prophylaxis and Management

More information

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections CARRIE ARMSTRONG Guideline source: Surgical Infection Society, Infectious Diseases Society of America Literature search described?

More information

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after

More information

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER CHAPTER 5 Dosage Calculations L earning Objectives After completing this chapter, you should be able to: Solve one-step pharmaceutical dosage calculations. Set up a series of ratios and proportions to

More information

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES Principles of prophylaxis 1) Use antimicrobials for surgical procedures where prophylactic antimicrobials have been found to be beneficial.

More information

Medication Calculation Practice Problems

Medication Calculation Practice Problems 1 Medication Calculation Practice Problems Dosage Calculation 1. The order is for 60 mg of furosemide (Lasix) po daily. Available to the nurse is Lasix 40 mg/tablet. The nurse would administer how many

More information

Outpatient Parenteral Antimicrobial Therapy

Outpatient Parenteral Antimicrobial Therapy Outpatient Parenteral Antimicrobial Therapy Jason E. Bowling, MD a,b, *, James S. Lewis II, PharmD c,d, Aaron D. Owens, MD a,e KEYWORDS Outpatient parenteral antimicrobial therapy Antibiotics Adverse events

More information

Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore

Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore Research Article Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore HS. Shekar 1*, HR. Chandrashekhar 2, M. Govindaraju 3, P. Venugopalreddy 1, Chikkalingiah

More information

A t f e t r e r th t is s lec e t c u t re r e t h t e e st s u t den e t t sh s ould b e e a b a le e t o t :

A t f e t r e r th t is s lec e t c u t re r e t h t e e st s u t den e t t sh s ould b e e a b a le e t o t : Dermatopharmacology Prof Werner Sinclair Department of Dermatology University of the Free State Outcomes for this Lecture After this lecture the student should be able to: Name the most important characteristics

More information

Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms.

Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms. Nazarchuk Oleksandr, Nahaichuk Vasyl, Paliy Viktor, Kovalenko Iryna. Microbiological aspects of the effectiveness of antimicrobial drugs. Journal of Education, Health and Sport. 2015;5(6):19-28. ISSN 2391-8306.

More information

How To Treat Mrsa From A Dead Body

How To Treat Mrsa From A Dead Body HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on

More information

Controversies in Hospital Medicine: Antifungal Therapy. Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters

Controversies in Hospital Medicine: Antifungal Therapy. Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters Controversies in Hospital Medicine: Antifungal Therapy Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado

More information

IDSA GUIDELINES EXECUTIVE SUMMARY

IDSA GUIDELINES EXECUTIVE SUMMARY IDSA GUIDELINES Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Joseph

More information

PROJECT LIST GENERIC PRODUCTS

PROJECT LIST GENERIC PRODUCTS PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets

More information

Bioequivalence Study Design Considerations. Dr. John Gordon

Bioequivalence Study Design Considerations. Dr. John Gordon Bioequivalence Study Design Considerations Dr. John Gordon Key Output of Programme A list of prequalified medicinal products used for treatment of HIV/AIDS, malaria, tuberculosis, influenza, and for reproductive

More information

Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV

Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV The purpose of this document is to provide additional clarification to the existing information

More information

Health PEI: Provincial Antibiotic Advisory Team Skin & Soft Tissue Infection Empiric Treatment Guidelines Prevention

Health PEI: Provincial Antibiotic Advisory Team Skin & Soft Tissue Infection Empiric Treatment Guidelines Prevention Syndrome Cellulitis / Erysipelas/ Necrotizing Fasciitis If Fournier s gangrene (pelvic / genital area gangrene) suspected: same treatment as severe sepsis. PLEASE NOTE: Redness and edema increase for 1-2

More information

SUMMARY REPORT. Antimicrobials Sold or Distributed for Use in Food-Producing Animals

SUMMARY REPORT. Antimicrobials Sold or Distributed for Use in Food-Producing Animals 2009 SUMMARY REPORT On Antimicrobials Sold or Distributed for Use in Food-Producing Animals Food and Drug Administration Department of Health and Human Services September, 20 This version supersedes the

More information

Chapter Four: Treatment of Tuberculosis Disease

Chapter Four: Treatment of Tuberculosis Disease Chapter Four: Treatment of Tuberculosis Disease The standard of tuberculosis (TB) treatment in Los Angeles County (LAC) is to initiate an appropriate chemotherapeutic regimen along with Directly Observed

More information

Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery 600 ASHP Therapeutic Guidelines Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP),

More information

PPP 1. Continuation of a medication to ensure continuity of care

PPP 1. Continuation of a medication to ensure continuity of care PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT

STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT RELEASE DATE: REVIEW INTERVAL: YEARLY REVIEW DATE: SITE/SERVICE UNIT: IMPLEMENTATION DATE: REVIEWED BY: CONTACT: APPROVED BY: CONTENTS

More information

SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance

SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance SEA-HLM-415 Distribution: General Establishment of national laboratory-based surveillance of antimicrobial resistance World Health Organization 2011 All rights reserved. Requests for publications, or for

More information

CICLOSPORIN. What are the aims of this leaflet?

CICLOSPORIN. What are the aims of this leaflet? CICLOSPORIN What are the aims of this leaflet? This leaflet has been written to help you understand more about ciclosporin. It tells you what it is, how it works, how it is used to treat skin conditions,

More information

GUIDELINES ON UROLOGICAL INFECTIONS

GUIDELINES ON UROLOGICAL INFECTIONS GUIDELINES ON UROLOGICAL INFECTIONS (Text update April 2010) M. Grabe (chairman), T.E. Bjerklund-Johansen, H. Botto, M. Çek, K.G. Naber, R.S. Pickard, P. Tenke, F. Wagenlehner, B. Wullt Introduction Infections

More information

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria

More information

GUIDELINES ON UROLOGICAL INFECTIONS

GUIDELINES ON UROLOGICAL INFECTIONS GUIDELINES ON UROLOGICAL INFECTIONS (Text update April 2014) M. Grabe (chair), R. Bartoletti, T.E. Bjerklund-Johansen, M. Çek, K.G. Naber, R.S. Pickard, P. Tenke, F. Wagenlehner, B. Wullt Introduction

More information

APIC Text of Infection Control and Epidemiology. 4th Edition

APIC Text of Infection Control and Epidemiology. 4th Edition APIC Text of Infection Control and Epidemiology 4th Edition TERMS OF USE By downloading the materials made available to you on the Association for Professionals in Infection Control and Epidemiology, Inc.

More information

Antibiotic Prophylaxis for the Prevention of Infective Endocarditis and Prosthetic Joint Infections for Dentists

Antibiotic Prophylaxis for the Prevention of Infective Endocarditis and Prosthetic Joint Infections for Dentists PRACTICE ADVISORY SERVICE FAQ 6 Crescent Road, Toronto, ON Canada M4W 1T1 T: 416.961.6555 F: 416.961.5814 Toll Free: 1.800.565.4591 www.rcdso.org Antibiotic Prophylaxis for the Prevention of Infective

More information

Systemic Anti-Infective Periodontal Therapy. A Systematic Review

Systemic Anti-Infective Periodontal Therapy. A Systematic Review Systemic Anti-Infective Periodontal Therapy. A Systematic Review Anne D. Haffajee,* Sigmund S. Socransky,* and John C. Gunsolley * Department of Periodontology, The Forsyth Institute, Boston, Massachusetts.

More information

Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4

Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4 Antibiotic Classes Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Assistant Professor of Clinical Medicine and Epidemiology Beta-lactams Inhibit cell wall synthesis Penicillins Cephalosporins

More information

Optimizing Antimicrobial Susceptibility Test Reporting

Optimizing Antimicrobial Susceptibility Test Reporting JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2011, p. S15 S19 0095-1137/11/$12.00 doi:10.1128/jcm.00712-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. VOL. 49, NO. 9 SUPPL. Optimizing

More information

Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Contents

Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Contents Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine

More information

Management of HIV and TB Co-infection in South Africa

Management of HIV and TB Co-infection in South Africa Management of HIV and TB Co-infection in South Africa Halima Dawood Department of Medicine Case Report 39 yr old female Referred to clinic on 14/06/2006 for consideration to commence antiretroviral therapy

More information

Management of Tuberculosis: Indian Guidelines

Management of Tuberculosis: Indian Guidelines Chapter 105 Management of Tuberculosis: Indian Guidelines Kuldeep Singh Sachdeva INTRODUCTION Tuberculosis (TB) is an infectious disease caused predominantly by Mycobacterium tuberculosis and among the

More information

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h See EMR adult VTE prophylaxis CI order set Enoxaparin See service specific dosing Assess

More information

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data

More information

How To Treat Mrsa In Finnish

How To Treat Mrsa In Finnish HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on

More information

ANTICOAGULANT DRUG INTERACTIONS. New Agents, New Concerns

ANTICOAGULANT DRUG INTERACTIONS. New Agents, New Concerns ANTICOAGULANT DRUG INTERACTIONS New Agents, New Concerns Ann K Wittkowsky PharmD, CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services UWMedicine

More information

How To Get A Drug Plan To Pay For A Prescription From Acpa

How To Get A Drug Plan To Pay For A Prescription From Acpa +B/LVW2I'UXJV5B$SSURYHG 2015 List of Covered s (Formulary) FOR MORE INFORMATION, contact Member Services at 1-855-735-4398 from 8 a.m. to 8 p.m., seven days a week. TTY users call 711. On weekends and

More information

Health (Drugs and Poisons) Regulation 1996. Drug Therapy Protocol Rural and Isolated Practice Area Endorsed Nurse

Health (Drugs and Poisons) Regulation 1996. Drug Therapy Protocol Rural and Isolated Practice Area Endorsed Nurse Health (Drugs and Poisons) Regulation 1996 Drug Therapy Protocol Rural and Isolated Practice Area Endorsed Nurse Health Protection Unit Medicines Regulation and Quality PO Box 21 Fortitude Valley BC QLD

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information

Frequently Asked Questions

Frequently Asked Questions Guidelines for Testing and Treatment of Gonorrhea in Ontario, 2013 Frequently Asked Questions Table of Contents Background... 1 Treatment Recommendations... 2 Treatment of Contacts... 4 Administration

More information

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships

More information

BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients. Drug Benefit List. Updated February 15, 2016

BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients. Drug Benefit List. Updated February 15, 2016 BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients Drug Benefit List Updated February 15, 2016 The FSDP will operate following rules established by the

More information

Illinois Valley Community College Nursing Program Math Questions

Illinois Valley Community College Nursing Program Math Questions Illinois Valley Community College Nursing Program Math Questions 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. How many mg of the antibiotic Penicillin would you prepare for a child who weighs

More information

SLIDING SCALE INSULIN ASPART PROTOCOL PLAN

SLIDING SCALE INSULIN ASPART PROTOCOL PLAN Weight Allergies Patient Care Accucheck Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Protocol Follow SSI Reference Text Medications

More information

Antimicrobial Audit. Philip Howard Consultant Antimicrobial Pharmacist. Medicines Management & Pharmacy Services

Antimicrobial Audit. Philip Howard Consultant Antimicrobial Pharmacist. Medicines Management & Pharmacy Services Antimicrobial Audit Philip Howard Consultant Antimicrobial Pharmacist Leeds Teaching Hospitals NHS Trust (North of England) Serves population 900k plus 2.5m for tertiary services ~ 2300 inpatient beds

More information

Recent Advances in The Treatment of Mycobacterium Tuberculosis

Recent Advances in The Treatment of Mycobacterium Tuberculosis Recent Advances in The Treatment of Mycobacterium Tuberculosis Dr Mohd Arif Mohd Zim Senior Lecturer & Respiratory Physician Faculty of Medicine, Universiti Teknologi MARA [email protected]

More information

Urinary Tract Infection and Asymptomatic Bacteriuria Guidance

Urinary Tract Infection and Asymptomatic Bacteriuria Guidance Urinary Tract Infection and Asymptomatic Bacteriuria Guidance Urinary tract infection (UTI) is the most common indication for antimicrobial use in hospitals and a significant proportion of this use is

More information

Health (Drugs and Poisons) Regulation 1996. Drug Therapy Protocol Midwives

Health (Drugs and Poisons) Regulation 1996. Drug Therapy Protocol Midwives Health (Drugs and Poisons) Regulation 1996 Drug Therapy Protocol Midwives Health Protection Unit Medicines Regulation and Quality PO Box 21 Fortitude Valley BC QLD 4006 Telephone (07) 3328 9808 Facsimile

More information

Dosage Calculation. Key Terms. Learning Outcomes

Dosage Calculation. Key Terms. Learning Outcomes 6 Dosage Calculation Key Terms Amount to dispense Desired dose Dosage ordered Dosage strength Dosage unit Dose on hand Estimated Days Supply Learning Outcomes When you have successfully completed Chapter

More information

Section 2 Solving dosage problems

Section 2 Solving dosage problems Section 2 Solving dosage problems Whether your organization uses a bulk medication administration system or a unit-dose administration system to prepare to administer pediatric medications, you may find

More information

Guideline. Treatment of tuberculosis in pregnant women and newborn infants. Version 3.0

Guideline. Treatment of tuberculosis in pregnant women and newborn infants. Version 3.0 Guideline Treatment of tuberculosis in pregnant women and newborn infants Version 3.0 Key critical points The decision to treat tuberculosis (TB) in pregnancy must consider the potential risks to mother

More information

Prescription Drug Guide

Prescription Drug Guide 2012 Prescription Drug Guide Humana Group Medicare Formulary List of covered drugs Humana Group Medicare Plus 3 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Y0040_PDG12b_Final_522C

More information